Literature DB >> 32378226

A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis.

Awanish Kumar1, Satish Chandra Pandey2,3, Mukesh Samant2.   

Abstract

Leishmania donovani (a causative agent of visceral leishmaniasis) poses a serious health threat to the human population which is fatal if left untreated. The life cycle of Leishmania alternates between vertebrate host and Phlebotomine fly as intermediate ones. Due to the difficulties linked to vector (sandfly) control and the lack of an effective vaccine, the control of leishmaniasis relies mostly on chemotherapy. Unfortunately, the prevalence of parasites becoming resistant to the first-line drug pentavalent antimonial (SbV )/sodium antimony gluconate (SAG) and some other anti-leishmanial drug is increasing in several parts of the world. With the alarming rise of drug resistance and other issues related to VL, there is an urgent need to focus on early detection and quick diagnosis of VL case. Therefore, we have reviewed most of the methods used in the diagnostic process of VL. Along with existing diagnostic methods, developing more effective and sensitive diagnostic methods and biomarkers is also vital for enhancing VL identification and control programs. This review gathers the comprehensive information on diagnostics methods of VL under a single umbrella that could be the prominent tools for the development of rapid, accurate and cost-effective diagnostic kits for VL which can be used in field conditions.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  diagnosis methods; drug resistance; parasite identification; visceral leishmaniasis

Year:  2020        PMID: 32378226     DOI: 10.1111/pim.12727

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  7 in total

Review 1.  The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses.

Authors:  Anand Kumar Gupta; Sonali Das; Mohd Kamran; Sarfaraz Ahmad Ejazi; Nahid Ali
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

2.  Cytokines and splenic remodelling during Leishmania donovani infection.

Authors:  Marcela Montes de Oca; Christian R Engwerda; Paul M Kaye
Journal:  Cytokine X       Date:  2020-09-01

3.  Case Report: Leishmania and HIV Co-Diagnosis: How to Understand Medical History?

Authors:  Arthur Dujardin; Arnaud de La Blanchardière; Julia Dina; Karl Stefic; Christophe Ravel; Julie Bonhomme; Renaud Verdon; Anna Lucie Fournier
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

4.  Computational System Level Approaches for Discerning Reciprocal Regulation of IL10 and IL12 in Leishmaniasis.

Authors:  Shweta Khandibharad; Shailza Singh
Journal:  Front Genet       Date:  2022-01-19       Impact factor: 4.599

5.  Identification of Leishmania tropica from Pediatric Visceral Leishmaniasis in Southern Mediterranean Region of Turkey.

Authors:  Derya Alabaz; Fadime Eroğlu; Hüseyin Elçi; Ümmühan Çay
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-07-01       Impact factor: 3.122

6.  Development and Clinical Evaluation of Serum and Urine-Based Lateral Flow Tests for Diagnosis of Human Visceral Leishmaniasis.

Authors:  Sarfaraz Ahmad Ejazi; Somsubhra Thakur Choudhury; Anirban Bhattacharyya; Mohd Kamran; Krishna Pandey; Vidya Nand Ravi Das; Pradeep Das; Fernando Oliveira da Silva; Dorcas Lamounier Costa; Carlos Henrique Nery Costa; Mehebubar Rahaman; Rama Prosad Goswami; Nahid Ali
Journal:  Microorganisms       Date:  2021-06-23

7.  DDX3 DEAD-box RNA helicase (Hel67) gene disruption impairs infectivity of Leishmania donovani and induces protective immunity against visceral leishmaniasis.

Authors:  Satish Chandra Pandey; Veena Pande; Mukesh Samant
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.